SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma

SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma

書誌詳細
主要な著者:	Chiara Rusconi, Giulio Cassanello, Anna Guidetti, Chiara Oltolini, Vincenzo Marasco, Lucio Morabito, Matteo Della Porta, Rodolfo Lanocita, Gabriele Papagni, Cristiana Carniti, Paolo Corradini
フォーマット:	論文
言語:	English
出版事項:	Wiley 2020-10-01
シリーズ:	HemaSphere
オンライン･アクセス:	http://journals.lww.com/10.1097/HS9.0000000000000472

類似資料

P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
著者:: Chiara Rusconi, 等
出版事項: (2022-10-01)

P1070: DECISIONAL ROLE OF INTERIM PET IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH BEGEV CHEMOTHERAPY AS FIRST SALVAGE
著者:: Chiara Rusconi, 等
出版事項: (2023-08-01)

P006: Clinical outcome of classical Hodgkin Lymphoma patients receiving systemic anti-lymphoma treatment during SARS-COV-2 positivity: Results from the chemo-covid study on behalf of fondazione italiana linfomi
著者:: Chiara Rusconi, 等
出版事項: (2022-10-01)

Safety of Tocilizumab on Rheumatoid Arthritis in Patients with Interstitial Lung Disease
著者:: Otsuji N, 等
出版事項: (2024-06-01)

Rapid Antibody Testing for SARS-CoV-2 in Asymptomatic and Paucisymptomatic Healthcare Professionals in Hematology and Oncology Units Identifies Undiagnosed Infections
著者:: Paolo Corradini, 等
出版事項: (2020-06-01)

Genetics of classical Hodgkin Lymphoma
著者:: Gianluca Schiavoni, 等
出版事項: (2018-06-01)

Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis–Related Interstitial Lung Disease
著者:: Vivekanand Tiwari, 等
出版事項: (2022-02-01)

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
著者:: Paolo F. Caimi, 等
出版事項: (2021-10-01)

Immune checkpoint inhibitors in combination with radiotherapy as salvage treatment for relapsed/refractory classical Hodgkin lymphoma: A retrospective analysis in 12 patients
著者:: Elisa Lucchini, 等
出版事項: (2021-06-01)

Controversies in the Treatment of Classical Hodgkin Lymphoma
著者:: Dennis A. Eichenauer, 等
出版事項: (2018-10-01)

Classical Hodgkin’s Lymphoma Presenting as Erythroderma
著者:: Kumar Parimalam, 等
出版事項: (2022-11-01)

Tocilizumab modulates the activity of the classical and alternative complement pathways in rheumatoid arthritis patients
著者:: Iván Ferraz-Amaro, 等
出版事項: (2025-01-01)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
著者:: Ahmet Dogan
出版事項: (2022-10-01)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
著者:: Irene Biasoli, 等
出版事項: (2023-11-01)

P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma
著者:: Andrea Visentin, 等
出版事項: (2022-10-01)

Evolution of drug therapy for classical Hodgkin lymphoma
著者:: N. Y. Samaneva, 等
出版事項: (2022-09-01)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
著者:: Mikalai Katsin, 等
出版事項: (2023-12-01)

Current directions in the treatment of classical Hodgkin lymphoma
著者:: Frank G. Keller, 等
出版事項: (2023-11-01)

Treatment Of Classical Hodgkin Lymphoma: The State Of The Art
著者:: Carmino Antonio de Souza, 等
出版事項: (2023-10-01)

Bone marrow involvement by classic Hodgkin lymphoma
著者:: Mohammad Barouqa, 等
出版事項: (2022-05-01)

Aberrant synaptophysin expression in classic Hodgkin lymphoma
著者:: Soyoung Im, 等
出版事項: (2022-11-01)

Bob-1 is expressed in classic Hodgkin lymphoma
著者:: Abd El All Howayda S
出版事項: (2007-03-01)

Relapsed and refractory classical Hodgkin lymphoma immunotherapy
著者:: Kirill Lepik
出版事項: (2020-10-01)

Composite follicular lymphoma and classic Hodgkin lymphoma
著者:: Han-Na Kim, 等
出版事項: (2022-01-01)

Update on tocilizumab in rheumatoid arthritis: a narrative review
著者:: Simone Parisi, 等
出版事項: (2025-02-01)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
著者:: Rossella Talotta, 等
出版事項: (2018-06-01)

Tocilizumab (Actemra)
著者:: Martin Sheppard, 等
出版事項: (2017-09-01)

The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future
著者:: S. E. Richardson, 等
出版事項: (2011-01-01)

Hemophagocytic Lymphohistiocytosis in a Patient with Classical Hodgkin Lymphoma
著者:: G. Hyun, 等
出版事項: (2016-01-01)

Classic Hodgkin lymphoma-nodular sclerosis – case report
著者:: Mihaela Lebedenco, 等
出版事項: (2023-06-01)

Optimization of the first line treatment in classical Hodgkin's lymphoma
著者:: Pauline Brice
出版事項: (2018-06-01)

Cell-Free DNA for the Management of Classical Hodgkin Lymphoma
著者:: Vincent Camus, 等
出版事項: (2021-03-01)

An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma
著者:: Isacco Ferrarini, 等
出版事項: (2023-02-01)

The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma
著者:: Lai C, 等
出版事項: (2019-12-01)

P014 (0098) CD47 IS EXPRESSED ON HODGKIN REED STERNBERG CELLS IN CLASSICAL HODGKIN LYMPHOMA
出版事項: (2018-10-01)

Reed-Sternberg and Hodgkin cells in bone marrow aspirate from a classical Hodgkin lymphoma patient
著者:: Leonardo Rodrigues Oliveira, 等
出版事項: (2022-04-01)

P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers
著者:: Simonetta Viviani, 等
出版事項: (2022-10-01)

Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes
著者:: Jonas Juul Hansen, 等
出版事項: (2018-01-01)

Severe Aplastic Anemia as First Manifestation of Classical Hodgkin Lymphoma
著者:: Cláudia L. Pedrosa, 等
出版事項: (2021-01-01)

Cerebellar involvement in classical Hodgkin’s lymphoma: A case report
著者:: Suyash Chinchanikar, 等
出版事項: (2024-09-01)